Presenter: Prof. Jong Seung Kim, Member of Korea Academy of Science &Technology

Department of Chemistry (College ofScience), Korea University

Title: AntitumorTheranostics and Its Delivery Sensing

Time: 4:00 PM, Aug 29

Location: 909B

Abstract

The advances in genomics, proteomics,and bioinformatics have directed the development of new anticancer agents toreduce drug abuse and increase safe and specific drug treatment. Theranostics,combining therapy and diagnosis, is an appealing approach for chemotherapy inmedicine which exhibit improved biodistribution, selective cancer targetingability, reduced toxicity, masked drug efficacy, and minimum side effects. Therole of diagnosis tool in theranostic is to collect the information of diseasedstate before and after specific treatment. Magnetic particle-, mesoporoussilica-, various carbon allotrope-, and polymer nanoparticle-based theranosticsystems are well accepted and clinically significant. Currently, smallconjugate-based systems have received much attention for cancer treatment anddiagnosis. The structural architecture of these systems is relatively simple,compact, biocompatible, and unidirectional. In this talk, the latestdevelopments on small conjugate based theranostic agents for tumor treatmentand diagnosis using fluorescence undertaken in my lab will be given.

Biography

Jong Seung Kim was born in Daejon,Korea in 1963. He received Ph.D. from Department of Chemistry and Biochemistryat Texas Tech University. After one-year postdoctoral fellowship at Universityof Houston, he joined the faculty at Konyang University in 1994 and transferredto Dankook University in 2003. In 2007, he then moved to the Department ofChemistry at Korea University in Seoul as a professor. To date, his researchrecords 355 scientific publications (citation = 16700, H index = 68) and 50domestic and international patents. He became the Member of Korea Academy ofScience and Technology in 2014.

Contact: Prof. Zhuang Liu

（责任编辑：张伶  邮箱：462696345@qq.com）